Literature DB >> 16139577

Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep.

A Sachse1, A Wagner, M Keller, O Wagner, W-D Wetzel, F Layher, R-A Venbrocks, P Hortschansky, M Pietraszczyk, B Wiederanders, H J Hempel, J Bossert, J Horn, K Schmuck, J Mollenhauer.   

Abstract

Osteointegration of metal implants into aged organisms can be severely compromised due to reduced healing capacity of bone, lack of precursor cells for new bone formation, or osteoporosis. Here, we report on successful implant healing in a novel model of aged sheep in the presence of nonglycosylated bone morphogenetic protein 2 (BMP-2). Ewes of 8 to 12 years with significant radiologic and histologic signs of osteoporosis and adipocytic bone marrow received a cylindrical hydroxyapatite-titanium implant of 12 x 10 mm. BMP-2 has been produced as a bacterial recombinant fusion protein with maltose-binding protein and in vitro generation of mature BMP-2 by renaturation and proteolytic cleavage. A BMP-2 inhibition ELISA was developed to measure the in vitro release kinetics of bioactive human BMP-2 from immersed solid implant materials by using Escherichia coli expressed and biotinylated recombinant human BMP-2 receptor IA extracellular domain (ALK-3 ECD). The implants were placed laterally below both tibial plateaus, with the left leg implant carrying 380 microg BMP-2. Both implant types became integrated within the following 20 weeks. The control implant only integrated at the cortical bone, and little new bone formation was found within the pre-existing trabecular bone or the marrow cavity. Marrow fat tissue was partially replaced by unspecific connective tissue. In contrast, BMP-2-coated implants initiated significant new bone formation, initially in trabecular arrangements to be replaced by cortical-like bone after 20 weeks. The new bone was oriented towards the cylinder. Highly viable bone marrow appeared and filled the lacunar structures of the new bone. In mechanical tests, the BMP-2-coated implants displayed in average 50% higher stability. This animal model provided first evidence that application of nonglycosylated BMP-2 coated on solid implants may foster bone healing and regeneration even in aged-compromised individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139577     DOI: 10.1016/j.bone.2005.06.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  20 in total

1.  Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings.

Authors:  Nisarg J Shah; Md Nasim Hyder; Joshua S Moskowitz; Mohiuddin A Quadir; Stephen W Morton; Howard J Seeherman; Robert F Padera; Myron Spector; Paula T Hammond
Journal:  Sci Transl Med       Date:  2013-06-26       Impact factor: 17.956

2.  Effects of low dose FGF-2 and BMP-2 on healing of calvarial defects in old mice.

Authors:  Lyndon F Charles; Jessica L Woodman; Daisuke Ueno; Gloria Gronowicz; Marja M Hurley; Liisa T Kuhn
Journal:  Exp Gerontol       Date:  2015-02-12       Impact factor: 4.032

Review 3.  Preclinical and Translational Studies in Small Ruminants (Sheep and Goat) as Models for Osteoporosis Research.

Authors:  Isabel R Dias; José A Camassa; João A Bordelo; Pedro S Babo; Carlos A Viegas; Nuno Dourado; Rui L Reis; Manuela E Gomes
Journal:  Curr Osteoporos Rep       Date:  2018-04       Impact factor: 5.096

4.  Influence of hydroxyapatite-coated and growth factor-releasing interference screws on tendon-bone healing in an ovine model.

Authors:  Yan Lu; Mark D Markel; Brett Nemke; J Sam Lee; Ben K Graf; William L Murphy
Journal:  Arthroscopy       Date:  2009-11-06       Impact factor: 4.772

5.  Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone.

Authors:  Liisa T Kuhn; Guomin Ou; Lyndon Charles; Marja M Hurley; Craig M Rodner; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-26       Impact factor: 6.053

6.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.

Authors:  Kai Heinecke; Axel Seher; Werner Schmitz; Thomas D Mueller; Walter Sebald; Joachim Nickel
Journal:  BMC Biol       Date:  2009-09-07       Impact factor: 7.431

7.  Fibroblast growth factor-2 isoform (low molecular weight/18 kDa) overexpression in preosteoblast cells promotes bone regeneration in critical size calvarial defects in male mice.

Authors:  Liping Xiao; Daisuke Ueno; Sylvain Catros; Collin Homer-Bouthiette; Lyndon Charles; Liisa Kuhn; Marja M Hurley
Journal:  Endocrinology       Date:  2014-01-09       Impact factor: 4.736

8.  Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.

Authors:  Katherine A Blackwell; Peter Hortschansky; Srdan Sanovic; Shilpa Choudhary; Lawrence G Raisz; Carol C Pilbeam
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-09-08       Impact factor: 3.072

9.  In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.

Authors:  Elisabet Segredo-Morales; Ricardo Reyes; María Rosa Arnau; Araceli Delgado; Carmen Évora
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

10.  The old sheep: a convenient and suitable model for senile osteopenia.

Authors:  Stefan Maenz; Olaf Brinkmann; Raimund W Kinne; Matthias Bungartz; Ines Hasenbein; Christina Braun; Elke Kunisch; Victoria Horbert; Francesca Gunnella; André Sachse; Sabine Bischoff; Harald Schubert; Klaus D Jandt; Jörg Bossert; Dominik Driesch
Journal:  J Bone Miner Metab       Date:  2020-04-15       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.